For the full year, analysts expect Rocket Lab's revenue to surge 74% to $425 million, with an adjusted EBITDA margin of -23%.

Investors happily greeted the latest news from Abbott Laboratories ( ABT 1.52%) on Hump Day. After the storied healthcare ...

Shares of Rocket Lab (NASDAQ: RKLB) jumped as much as 13.4 ... On rare occasions, our expert team of analysts issues a “Double Down” stock recommendation for companies that they think are ...

Abbott Laboratories is a diversified healthcare company with strong segments, particularly Medical Devices. Read why I assign ...

Rocket Lab USA shares are getting a lift in Thursday's after-hours session following a report that the Biden administration ...

The new lab was announced at the HLTH conference in Las Vegas this week, said Parminder Bhatia, GE HealthCare’s chief AI ...

Once dismissed as a conspiracy theory, the idea that Covid-19 originated in a virology lab in Wuhan now has many adherents ...

Abbott Laboratories shares rose Wednesday after the drug and healthcare products maker reported better-than-expected ...

That's the good news. The bad news came a few hours later: Rocket Lab just announced it will report Q3 financial results on Nov. 12, and its stock fell 2.9% through 3:25 p.m. ET. Let's start with ...

Even the best lab-grown diamonds can stir up a bit of skepticism in shoppers—and for good reason. You might wonder: How can anything concocted in a laboratory compare to what’s organically ...

Rocket Lab's shares have taken off. The twin positives of lower interest rates and better-than-expected inflation data seem to have bypassed the sharemarket. Official data this week showed ...